Moreover, CSCs can undergo epithelial-mesenchymal transition (EMT), and FGF19/FGFR4 signaling has been implicated in this process in colorectal cancer and hepatocellular carcinoma [66,67]. Here, FGFR4 is linked to hepatocellular carcinoma.